Valuation BioMarin Pharmaceutical Inc.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 08/05/2026 am IST			5-day change	1st Jan Change
54.12 ^USD	-0.88%		+0.39%	-8.93%

05/05	BioMarin Pharmaceutical Q1 Revenue Beat Backed by Voxzogo Strength, Diversified Portfolio, Wedbush Says	MT
05/05	BioMarin Enters 'Transition Year' as Enzyme Portfolio Expands After Amicus Deal, Morgan Stanley Says	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Capitalization ¹	16,220	19,234	18,162	12,527	11,417	10,460	-	-
Change	-	18.58%	-5.57%	-31.03%	-8.86%	-8.39%	-	-
Enterprise Value (EV) ¹	15,778	19,592	18,176	11,984	10,454	13,409	12,524	11,282
Change	-	24.17%	-7.23%	-34.06%	-12.77%	28.27%	-6.6%	-9.91%
P/E ratio	-252x	138x	111x	29.7x	33x	15.9x	10.6x	8.52x
PBR	3.8x	4.25x	3.67x	2.22x	-	1.52x	1.24x	1.07x
PEG	-	-0x	6.9x	0x	-1.8x	0.2x	0.2x	0.4x
Capitalization / Revenue	8.79x	9.18x	7.51x	4.39x	3.54x	2.7x	2.37x	2.17x
EV / Revenue	8.55x	9.35x	7.51x	4.2x	3.25x	3.46x	2.83x	2.34x
EV / EBITDA	614x	77.9x	69.2x	20.6x	21.4x	15.4x	11.4x	8.93x
EV / EBIT	-192x	131x	115x	24.8x	25.5x	29.5x	8.7x	6.7x
EV / FCF	75.5x	357x	290x	24.6x	14.4x	13.8x	11.5x	8.25x
FCF Yield	1.32%	0.28%	0.34%	4.07%	6.93%	7.25%	8.68%	12.1%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-0.35	0.75	0.87	2.21	1.8	3.394	5.109	6.353
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	1,846	2,096	2,419	2,854	3,221	3,871	4,418	4,816
EBITDA ¹	25.7	251.5	262.5	580.6	489	871.6	1,096	1,263
EBIT ¹	-82.34	149.6	158.1	484.2	409.5	455.2	1,439	1,685
Net income ¹	-64.08	141.6	167.6	426.9	348.9	693.5	1,030	1,255
Net Debt ¹	-442.6	358.5	13.16	-542.6	-963.4	2,949	2,064	822.6
Reference price ²	88.35	103.49	96.42	65.73	59.43	54.12	54.12	54.12
Nbr of stocks (in thousands)	1,83,593	1,85,849	1,88,368	1,90,583	1,92,114	1,93,270	-	-
Announcement Date	23/02/22	27/02/23	22/02/24	19/02/25	23/02/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
BIOMARIN PHARMACEUTICAL INC.	15.94x	3.46x	15.38x	-.--%	1.05TCr
REGENERON PHARMACEUTICALS, INC.	18.42x	4.07x	10.98x	0.55%	7.21TCr
UCB	25.27x	5.06x	14.59x	0.63%	5.22TCr
SAMSUNG BIOLOGICS CO.,LTD.	35.67x	12.21x	22.37x	-.--%	4.68TCr
CSL LIMITED	32.1x	3.29x	9.51x	3.32%	4.29TCr
BIOGEN INC.	30.16x	3.38x	10.07x	-.--%	2.83TCr
INNOVENT BIOLOGICS, INC.	53.43x	6.74x	46.42x	-.--%	2.02TCr
INCYTE CORPORATION	14.75x	2.58x	8.04x	-.--%	1.95TCr
MODERNA, INC.	-5.59x	7.53x	-4.58x	-.--%	1.93TCr
SWEDISH ORPHAN BIOVITRUM AB	25.29x	5.15x	13.8x	-.--%	1.67TCr
Average	24.54x	5.35x	14.66x	0.45%	3.28TCr
Weighted average by Cap.	25.56x	5.54x	14.28x	0.66%